SQZ BIOTECHNOLOGIES COMPANY Earnings Per Share, Basic and Diluted
SQZ BIOTECHNOLOGIES COMPANY reported Earnings Per Share, Basic and Diluted of -$0.75 per share for the 3-month period ending 2022-03-31, per its 10-Q filed 2022-05-10.
Discontinued › Income Statement › Earnings Per Share
us-gaap:EarningsPerShareBasicAndDiluted · last filed 2022-05-10
- SQZ BIOTECHNOLOGIES COMPANY earnings per share, basic and diluted for the quarter ending 2022-03-31 was -$0.75.
- SQZ BIOTECHNOLOGIES COMPANY earnings per share, basic and diluted for the quarter ending 2021-12-31 was -$0.42.
- SQZ BIOTECHNOLOGIES COMPANY earnings per share, basic and diluted for the quarter ending 2021-09-30 was -$0.80.
- SQZ BIOTECHNOLOGIES COMPANY earnings per share, basic and diluted for the quarter ending 2021-06-30 was -$0.68.
- SQZ BIOTECHNOLOGIES COMPANY earnings per share, basic and diluted for fiscal 2021 was -$2.49.
- SQZ BIOTECHNOLOGIES COMPANY earnings per share, basic and diluted for fiscal 2020 was -$9.35.
- SQZ BIOTECHNOLOGIES COMPANY earnings per share, basic and diluted for fiscal 2019 was -$18.89.
| Period end | Earnings Per Share, Basic and Diluted 3 month | Earnings Per Share, Basic and Diluted 6 month | Earnings Per Share, Basic and Diluted 9 month | Earnings Per Share, Basic and Diluted 12 month |
|---|---|---|---|---|
| 2022-03-31 | -$0.75 10-Q · filed 2022-05-10 | -$1.17 derived: net income ÷ weighted average shares · filed 2023-05-10 | -$1.97 derived: net income ÷ weighted average shares · filed 2023-05-10 | -$2.65 derived: net income ÷ weighted average shares · filed 2023-05-10 |
| 2021-12-31 | -$0.42 derived: net income ÷ weighted average shares · filed 2023-03-22 | -$1.22 derived: net income ÷ weighted average shares · filed 2023-03-22 | -$1.90 derived: net income ÷ weighted average shares · filed 2023-03-22 | -$2.49 10-K · filed 2022-03-16 |
| 2021-09-30 | -$0.80 10-Q · filed 2021-11-10 | -$1.48 derived: net income ÷ weighted average shares · filed 2022-11-09 | -$2.08 10-Q · filed 2021-11-10 | -$3.02 derived: net income ÷ weighted average shares · filed 2022-11-09 |
| 2021-06-30 | -$0.68 10-Q · filed 2021-08-04 | -$1.27 10-Q · filed 2021-08-04 | -$2.21 derived: net income ÷ weighted average shares · filed 2022-08-04 | -$3.56 derived: net income ÷ weighted average shares · filed 2022-08-04 |
| 2021-03-31 | -$0.59 10-Q · filed 2022-05-10 | -$1.55 derived: net income ÷ weighted average shares · filed 2022-05-10 | -$3.06 derived: net income ÷ weighted average shares · filed 2022-05-10 | -$4.80 derived: net income ÷ weighted average shares · filed 2022-05-10 |
| 2020-12-31 | -$1.08 derived: net income ÷ weighted average shares · filed 2022-03-16 | -$3.30 derived: net income ÷ weighted average shares · filed 2022-03-16 | -$6.03 derived: net income ÷ weighted average shares · filed 2022-03-16 | -$9.35 10-K · filed 2022-03-16 |
| 2020-09-30 | -$7.03 10-Q · filed 2021-11-10 | -$12.77 derived: net income ÷ weighted average shares · filed 2021-11-10 | -$18.87 10-Q · filed 2021-11-10 | -$24.80 derived: net income ÷ weighted average shares · filed 2021-11-10 |
| 2020-06-30 | -$5.74 10-Q · filed 2021-08-04 | -$11.83 10-Q · filed 2021-08-04 | -$17.76 derived: net income ÷ weighted average shares · filed 2021-08-04 | -$22.35 derived: net income ÷ weighted average shares · filed 2021-08-04 |
| 2020-03-31 | -$6.09 10-Q · filed 2021-05-11 | -$12.02 derived: net income ÷ weighted average shares · filed 2021-05-11 | -$16.61 derived: net income ÷ weighted average shares · filed 2021-05-11 | |
| 2019-12-31 | -$5.93 derived: net income ÷ weighted average shares · filed 2021-03-18 | -$10.51 derived: net income ÷ weighted average shares · filed 2021-03-18 | -$18.89 10-K · filed 2021-03-18 | |
| 2019-09-30 | -$4.58 10-Q · filed 2020-12-10 | -$12.94 10-Q · filed 2020-12-10 |